Systematic review finds age and Galassi type influence pediatric middle fossa arachnoid cyst outcomes

This systematic review and meta-analysis investigated pediatric middle fossa arachnoid cysts (MFACs), focusing on how patient age and Galassi cyst type relate to clinical outcomes. The study included 1,024 pediatric patients with MFACs, though specific study settings, follow-up durations, and publication types were not reported. The intervention or exposure was defined as patient age and Galassi type, with no explicit comparator group, reflecting an observational design that examines associations rather than causal effects.

Primary outcomes were not specified, but key findings included prevalence estimates for various clinical features. Signs of elevated intracranial pressure (ICP) had a prevalence of 22.2% (194 out of 873 patients, 95% CI: 19.5-25.0%). Primary headaches were reported in 30.1% of cases (263 out of 873, 95% CI: 27.1-33.2%). Bilateral MFACs were more likely in younger patients at presentation, with an odds ratio (OR) of 0.71 (95% CI: 0.52-0.98, p = 0.034). Left laterality of MFACs was prevalent in 62.2% of cases (421 out of 677, 95% CI: 58.6-65.1%), and singular MFACs occurred in 96.8% (791 out of 817, 95% CI: 95.6-98.2%).

Secondary outcomes revealed further associations with age. Younger patients had a higher proportion of second operations (OR: 0.82, 95% CI: 0.72-0.93, p = 0.002) and cerebrospinal fluid (CSF) shunting (OR: 0.88, 95% CI: 0.79-0.97, p = 0.011). Complications showed no significant difference when comparing older children (5-18 years) to young children (≤ 4 years) (p = 0.737) or across Galassi types (p = 0.736). Management through observation was associated with Galassi type 1 (p = 0.019), though effect sizes and absolute numbers for this and some other outcomes were not reported.

Safety and tolerability data were not reported, including adverse events, serious adverse events, discontinuations, and tolerability profiles. This absence limits the ability to assess risks associated with interventions like surgery or shunting in this population.

Compared to prior landmark studies in pediatric neurosurgery, this review aggregates a large sample size to provide prevalence estimates and associations, but it does not establish causality or compare specific treatments. Previous research often focuses on surgical outcomes or cyst characteristics, whereas this analysis emphasizes demographic and morphological factors like age and Galassi type, offering a broader epidemiological perspective.

Key methodological limitations include the observational nature of the data, which precludes causal inferences, and gaps in reporting such as lack of primary outcomes, comparator details, and safety information. Potential biases may arise from selection bias in included studies or publication bias, though these were not explicitly addressed. The review also did not report funding sources or conflicts of interest, which could affect interpretation.

Clinical implications suggest that age and Galassi type may be useful for stratifying risk and guiding management decisions in pediatric MFACs. For instance, younger patients might require closer monitoring due to higher likelihood of bilateral cysts, repeat surgeries, and shunting, while Galassi type 1 cysts may be more amenable to observational approaches. However, these associations should inform rather than dictate practice, as individual patient factors and clinical judgment remain paramount.

Unanswered questions include the long-term outcomes of different management strategies, the optimal timing for interventions, and how age-related associations translate into specific treatment recommendations. Further research, particularly prospective studies or randomized trials, is needed to validate these findings and explore causal relationships, as well as to address safety concerns and refine clinical guidelines for this condition.